Oliver Lagore Vanvalin Investment Group Charles River Laboratories International, Inc. Transaction History
Oliver Lagore Vanvalin Investment Group
- $263 Million
- Q2 2025
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 40 shares of CRL stock, worth $7,093. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40Holding current value
$7,093% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding CRL
# of Institutions
616Shares Held
53.2MCall Options Held
1.42MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA5.81MShares$1.03 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$902 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.77MShares$668 Million0.11% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$406 Million0.63% of portfolio
-
State Street Corp Boston, MA1.86MShares$330 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.02B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...